FDA’s COVID-19 Activities

 

Learn about FDA’s regulatory pathways for the approval and investigation of products intended for the prevention and treatment of COVID-19. Understand actions that FDA has taken to assist industry during the COVID-19 pandemic. Become familiar with FDA COVID-19 enforcement.

Jacqueline R. Berman, Partner, Morgan, Lewis & Bockius LLP

This session was recorded as part of FDLI’s Virtual Introduction to Drug Law and Regulation Course in April 2021. 

 

 

Get Access

$99
  • +$100 for nonmembers

Virtual Learning FAQ

On-demand webinar content is sent via email as soon as we are able to process and verify your order. This usually occurs within 1 business day.

 

On-demand content can be played back on most devices.

 

CLE credit is not currently available for pre-recorded sessions.

Related Content